These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17636663)

  • 1. Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma.
    Tee AK; Koh MS; Gibson PG; Lasserson TJ; Wilson AJ; Irving LB
    Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001281. PubMed ID: 17636663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
    Shah L; Wilson AJ; Gibson PG; Coughlan J
    Cochrane Database Syst Rev; 2003; (3):CD001281. PubMed ID: 12917905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
    Wilson AJ; Gibson PG; Coughlan J
    Cochrane Database Syst Rev; 2000; (2):CD001281. PubMed ID: 10796631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled long acting beta agonists for stable chronic asthma.
    Walters EH; Walters JA; Gibson MD
    Cochrane Database Syst Rev; 2003; (4):CD001385. PubMed ID: 14583933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.
    Walters EH; Walters JA; Gibson PW
    Cochrane Database Syst Rev; 2002; 2002(4):CD003901. PubMed ID: 12519616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.
    Walters EH; Gibson PG; Lasserson TJ; Walters JA
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001385. PubMed ID: 17253458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Appleton S; Smith B; Veale A; Bara A
    Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.
    Appleton S; Poole P; Smith B; Veale A; Lasserson TJ; Chan MM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD001104. PubMed ID: 16855959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
    Holimon TD; Chafin CC; Self TH
    Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
    Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
    Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
    Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease.
    Appleton S; Jones T; Poole P; Pilotto L; Adams R; Lasserson TJ; Smith B; Muhammad J
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006101. PubMed ID: 16856113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
    Nannini L; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2003; (4):CD003794. PubMed ID: 14583994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of salmeterol and formoterol in patients with severe asthma.
    Nightingale JA; Rogers DF; Barnes PJ
    Chest; 2002 May; 121(5):1401-6. PubMed ID: 12006420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regular treatment with salmeterol for chronic asthma: serious adverse events.
    Cates CJ; Cates MJ
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006363. PubMed ID: 18646149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies.
    Davies B; Brooks G; Devoy M
    Respir Med; 1998 Feb; 92(2):256-63. PubMed ID: 9616522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.